Comments on: deCODE Launches PrCa Prostate Cancer DNA Test

By: Dr. Med Soweifi-Zentrum Für Prostatakrebs, Germany

Dr. Med Soweifi-Zentrum Für Prostatakrebs, Germany — Thu, 15 May 2008 13:47:46 +0000

Pretty surprising results of this study. since i am working in a european country, it makes sense to take many parts of it seriously. Thanks for posting it, i will get my hands on the complete study results very soon. Regards Dr. Atef.

By: deCODE CEO Predicts Dowswing in Personal Genomics Market

deCODE CEO Predicts Dowswing in Personal Genomics Market — Wed, 05 Mar 2008 13:24:17 +0000

[...] ProCa (previously named deCODE PrCa) - A genetic test for prostate [...]

By: Prostate Cancer | Old&New SNPs and deCODEPrCa « www.cancer-genetics.com

Fri, 15 Feb 2008 15:41:26 +0000

[...] sooner does one company launch a first-of-its-kind test than another launches a similar one”, Hsien at EyeOnDNA notes about this new [...]

By: Hsien-Hsien Lei, PhD

Hsien-Hsien Lei, PhD — Fri, 15 Feb 2008 15:08:50 +0000

One more thought as to value for money. If companies like deCODE and Proactive Genomics provide significantly more customer support, such as genetic counseling and detailed personalized report taking into account non-genetic risk factors, the extra cost of SNP-specific genetic testing could be worth it.

By: Hsien-Hsien Lei, PhD

Hsien-Hsien Lei, PhD — Fri, 15 Feb 2008 15:06:46 +0000

Shuen, I don’t know the answer to this but I’ll try to find out.

By: Hsien-Hsien Lei, PhD

Hsien-Hsien Lei, PhD — Fri, 15 Feb 2008 15:04:59 +0000

JJ, The PCA3 gene test analyzes urine samples NOT DNA meaning that it quantifies gene expression and not mutations.

By: J.J.

J.J. — Fri, 15 Feb 2008 14:52:00 +0000

Ann, I don’t really get what you’re saying. Can you clarify it once again? Thanks

By: Ann Turner

Ann Turner — Fri, 15 Feb 2008 11:45:56 +0000

No. From what I gather with a quick Google search, the PCA3 test quantifies the extent of gene expression. It’s not for variations within a gene.

By: J.J.

J.J. — Fri, 15 Feb 2008 10:55:23 +0000

Is the detection based on PCA3 gene?

By: Shuen Lo

Shuen Lo — Fri, 15 Feb 2008 05:35:35 +0000

I always assumed that Decode (and Proactive) owns the IP for its prostate cancer test, is it not true? If not, the entry barrier to the competitors would seem pretty low.